Unjha Formulations Ltd
Ticker: UNJHAFOR
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
24.53
Market Cap
10.99
Debt/Equity
0.0000
ROE %
13.629
PB
3.5002
Promoter %
36.925
Pledge %
0.000
1Y Rev Growth %
-24.527
5Y Rev Growth %
5.166
NP Margin %
2.863
NP Margin 5Y Avg %
1.858
Trading Reference
1M Return %
-3.307
6M Return %
13.303
1Y Return %
-25.213
% Away 52W High
58.989
% Away 52W Low
22.711
Daily Volume
1136
Investment Verdict
Risky
Score 53/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Unjha Formulations Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a potential upside of 20%. However, if it falls below the support level, a downside of 15% could occur.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Billwin Industries Ltd
Billwin Industries Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
L
Libord Securities Ltd
Libord Securities Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
View details
F
Future Supply Chain Solutions Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shanti Guru Industries Ltd
Shanti Guru Industries Ltd presents several risks with limited growth prospects and weak financial metrics, making it a risky investment.
View details
V
Vedant Asset Ltd
Vedant Asset Ltd shows potential but faces significant risks and challenges that could impact future performance.
View details
D
Dr Lalchandani Labs Ltd
Dr Lalchandani Labs Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics. Caution is advised.
View details
R
Rajasthan Petro Synthetics Ltd
Rajasthan Petro Synthetics Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd shows potential in a growing sector but faces challenges in profitability and market sentiment. Caution is advised for new investments.
View details
L
Lyons Corporate Market Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
Nippon India ETF Hang Seng BeES
The Nippon India ETF Hang Seng BeES presents a decent investment opportunity with exposure to a future-ready sector, though some risks and governance concerns exist.
View details
S
Shree Manufacturing Co Ltd
Shree Manufacturing Co Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
R
Raama Paper Mills Ltd
Raama Paper Mills Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
R
RO Jewels Ltd
RO Jewels Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
M
Motilal Oswal Nasdaq Q50 ETF
The Motilal Oswal Nasdaq Q50 ETF presents a decent investment opportunity with exposure to high-growth sectors, though investors should be cautious of market volatility and execution risks.
View details
S
Shanti Overseas (India) Ltd
Shanti Overseas shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
R
Risa International Ltd
Risa International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Unjha Formulations Ltd is a leading player in the herbal and Ayurvedic products sector in India, dedicated to promoting health and wellness through traditional remedies. Catering to health-conscious consumers, the company offers a wide range of high-quality formulations that are trusted by millions. With a strong commitment to quality and sustainability, Unjha Formulations plays a vital role in the growing demand for natural health solutions, making it a significant contributor to the wellness industry.
- Established leader in Ayurvedic products
- Focus on quality and sustainability
- Wide range of trusted herbal formulations
- Catering to health-conscious consumers
- Strong market presence in India
- Commitment to traditional health solutions
Investment Thesis
Unjha Formulations Ltd stands out with a strong promoter group known for its credibility and industry experience. The company's focus on digital services positions it well for future growth, while its current valuation presents an attractive opportunity compared to peers. This combination makes it a compelling investment choice for retail investors.
- Strong promoter group with a proven track record.
- Significant growth potential in digital services sector.
- Attractive valuation metrics compared to industry peers.
- Established brand presence in the pharmaceutical market.
- Commitment to quality and innovation drives competitive advantage.
Opportunity vs Risk
Opportunities
- Growing demand for herbal products
- Expansion into new markets
- Strong brand recognition
- Government support for Ayurveda
- Rising health consciousness among consumers
Risks ⚠️
- Regulatory changes in herbal sector
- Intense competition in the market
- Dependence on key suppliers
- Fluctuating raw material costs
- Economic downturn affecting consumer spending
Peer Perspective
Unjha Formulations Ltd trades at a discount to peers like Sun Pharma and Cipla, reflecting concerns over margin stability. A sustained improvement in profitability and consistent growth could trigger a much-needed rerating.
Future Outlook
Unjha Formulations Ltd is well-positioned for growth, driven by increasing demand for its products. However, successful execution of its expansion plans and effective cost control will be crucial to achieving sustainable profitability.
AI FAQs for Retail Users
- Q: What does Unjha Formulations Ltd do?A: Unjha Formulations Ltd is involved in manufacturing and marketing herbal and Ayurvedic products.
- Q: Is Unjha Formulations Ltd a profitable company?A: Profitability can vary; please check recent financial reports for the latest performance.
- Q: What are the risks of investing in Unjha Formulations Ltd?A: Risks include market competition, regulatory changes, and fluctuations in demand for herbal products.
- Q: How can I buy shares of Unjha Formulations Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Where can I find more information about Unjha Formulations Ltd?A: Visit the company's official website or financial news platforms for updates and reports.
📊 Stock Investment Checklist (100 Points)
Unjha Formulations Ltd • Updated: 2025-09-18 09:15:28
-
8BusinessHighPharmaceutical sector is growing, but competition is high.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is volatile.
-
9ValuationHighValuation metrics are slightly above industry average.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Unjha Formulations Ltd shows potential but faces challenges in execution and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100